Autonomic Nervous System Drugs Practice Questions

Q: Which of the following is a spasmolytic analgesic?

Dicyclomine. ### Explanation **1. Why Dicyclomine is the Correct Answer:** Dicyclomine is a **synthetic quaternary ammonium anticholinergic** drug. It acts as a direct smooth muscle relaxant and a competitive antagonist at muscarinic (M3) receptors. In the gastrointestinal tract, it reduces spasms of the smooth muscles, which effectively relieves the pain associated with intestinal colic or irritable bowel syndrome (IBS). Because it treats the cause of the pain (spasm) while providing relief, it is categorized as a **spasmolytic analgesic**. **2. Why the Other Options are Incorrect:** * **Physostigmine (Option B):** This is a tertiary amine **anticholinesterase** (parasympathomimetic). It increases acetylcholine levels at the synapse. Instead of relieving spasms, it would actually increase GI motility and potentially cause cramping. It is primarily used as an antidote for atropine poisoning. * **Tropicamide (Option C):** This is a short-acting **antimuscarinic** used exclusively in ophthalmology. It is applied topically to induce mydriasis (dilation of the pupil) and cycloplegia for fundus examination. It has no role as a systemic spasmolytic. **3. NEET-PG High-Yield Clinical Pearls:** * **Mechanism:** Dicyclomine has dual action—anticholinergic activity + direct non-specific smooth muscle relaxant activity. * **Clinical Use:** It is the drug of choice for **smooth muscle biliary, renal, or intestinal colic** and is frequently used in dysmenorrhea. * **Contraindications:** Like all anticholinergics, avoid in patients with **Glaucoma** (increases intraocular pressure) and **Prostatic Hypertrophy** (causes urinary retention). * **Other Spasmolytics:** Other drugs in this category include **Hyoscine (Scopolamine)** and **Drotaverine** (a PDE-4 inhibitor).

Q: Which of the following statements about Esmolol is true?

It is used in left ventricular decompensation.. **Explanation:** **Esmolol** is a unique, ultra-short-acting **beta-1 selective (cardioselective) blocker**. **Why Option D is Correct:** While beta-blockers are generally contraindicated in acute heart failure, Esmolol is specifically indicated for the management of **supraventricular tachyarrhythmias** or hypertension in patients with **left ventricular decompensation** (acute heart failure) or perioperative settings. Its "safety net" lies in its ultra-short duration of action; if the patient’s cardiac output drops further, the drug effect disappears within minutes of stopping the infusion, allowing for precise titration. **Analysis of Incorrect Options:** * **Option A:** Esmolol is a **Beta-blocker**, not an alpha-blocker. * **Option B:** It has an **extremely short half-life** (approximately 9 minutes). This is because it is rapidly hydrolyzed by **red blood cell esterases** (not by liver or kidney enzymes). * **Option C:** It is highly **cardioselective** (Beta-1 selective), making it safer for patients with reactive airway disease compared to non-selective blockers like Propranolol. **High-Yield Clinical Pearls for NEET-PG:** * **Route of Administration:** Always given **Intravenously (IV)**; never orally. * **Metabolism:** Hydrolysis by RBC esterases (Unique feature). * **Indications:** Aortic dissection (to reduce shear stress), Thyroid storm, and perioperative tachycardia/hypertension. * **Mnemonic:** Remember **"Esmolol is Easy-off"** due to its rapid offset of action.

Q: Which of the following statements is not true regarding Dobutamine?

Agonist of D1 and D2 receptors. **Explanation** **Dobutamine** is a synthetic catecholamine primarily used as an inotropic agent in the management of acute heart failure and cardiogenic shock. **1. Why Option A is the Correct Answer (The False Statement):** Unlike its parent compound Dopamine, **Dobutamine does not act on Dopaminergic (D1 and D2) receptors.** It lacks the specific structural components required to stimulate renal or mesenteric vasodilation via D1 receptors. Therefore, it does not directly increase renal blood flow through dopaminergic pathways. **2. Analysis of Other Options:** * **Option B (Derivative of Dopamine):** This is true. Dobutamine is a structural analogue of dopamine, synthesized by substituting a large chemical group on the amino nitrogen. * **Option C (Selective Beta-agonistic action):** This is true. It acts predominantly on **$\beta_1$ receptors** in the heart to increase contractility (inotropy) with a relatively lesser effect on heart rate (chronotropy). It has minor $\beta_2$ and $\alpha_1$ activity, but the net effect is potent inotropy. * **Option D (Reduced chances of arrhythmia):** This is true. Compared to Adrenaline or Isoprenaline, Dobutamine is less likely to cause significant tachycardia or provoke life-threatening arrhythmias at therapeutic doses, making it safer for cardiac patients. **Clinical Pearls for NEET-PG:** * **Drug of Choice:** Dobutamine is the preferred inotrope for **Cardiogenic Shock** (where BP is relatively stable) and **Stress Echocardiography** (to identify hibernating myocardium). * **Isomerism:** It is a racemic mixture; the (+) isomer is a $\beta$-agonist, while the (-) isomer is an $\alpha_1$-agonist. * **Half-life:** It has a very short half-life (~2 minutes), requiring continuous IV infusion. * **Tolerance:** Tachyphylaxis (diminished response) can occur with prolonged use (more than 72 hours) due to receptor down-regulation.

Q: Action of which of the following drugs is rapidly terminated?

Succinylcholine. **Explanation:** The correct answer is **Succinylcholine**. **Why Succinylcholine is correct:** Succinylcholine is a depolarizing neuromuscular blocker known for its **ultra-short duration of action** (typically 5–10 minutes). Its action is rapidly terminated because it is hydrolyzed by **Pseudocholinesterase (Butyrylcholinesterase)** found in the plasma. Unlike other neuromuscular blockers, it does not rely on hepatic metabolism or renal excretion for the termination of its primary effect, making it the drug of choice for rapid sequence intubation. **Why the other options are incorrect:** * **Atracurium:** This is an intermediate-acting non-depolarizing blocker (20–35 minutes). While it undergoes a unique "Hofmann elimination" (spontaneous non-enzymatic degradation), it is not as rapid as Succinylcholine. * **Pancuronium:** This is a long-acting steroid-based non-depolarizing blocker (duration >60 minutes). It is primarily eliminated by the kidneys and has a slow onset and offset. * **D-tubocurarine:** This is the prototype long-acting non-depolarizing blocker. It has a slow onset and a prolonged duration of action, largely due to its slow redistribution and renal excretion. **High-Yield Clinical Pearls for NEET-PG:** * **Succinylcholine Apnea:** Occurs in patients with a genetic deficiency of pseudocholinesterase, leading to prolonged paralysis. * **Phase II Block:** Occurs with high doses or continuous infusion of Succinylcholine, where the block changes from depolarizing to resembling a non-depolarizing block. * **Side Effects:** Watch for hyperkalemia (contraindicated in burn/trauma patients), malignant hyperthermia (treated with Dantrolene), and muscle fasciculations. * **Mnemonic:** Succinylcholine is "Succ-inct" (brief/short-acting).

Q: Which of the following is a phase I blocker?

Suxamethonium. ### Explanation Neuromuscular blocking agents (NMBAs) are classified into two main categories based on their mechanism of action at the nicotinic acetylcholine receptor (Nm) of the motor endplate: **Depolarizing** and **Non-depolarizing** blockers [1]. **1. Why Suxamethonium is Correct:** **Suxamethonium (Succinylcholine)** is the only clinically used **Depolarizing Neuromuscular Blocker** [2]. It acts as a **Phase I blocker** by mimicking acetylcholine; it binds to Nm receptors and causes persistent depolarization [2]. Because it is not metabolized by acetylcholinesterase (it is degraded by plasma pseudocholinesterase), the membrane remains depolarized and unresponsive to subsequent impulses, leading to flaccid paralysis preceded by fasciculations [3]. **2. Why the Other Options are Incorrect:** * **Atracurium, Gallamine, and D-Tubocurare:** These are all **Non-depolarizing Blockers** (Competitive Antagonists) [1]. They work by competing with acetylcholine for the Nm receptor without activating it. They do not cause initial depolarization or fasciculations and are often referred to as "pachycurares." **3. High-Yield Clinical Pearls for NEET-PG:** * **Phase II Block:** With prolonged or continuous infusion of Suxamethonium, the membrane repolarizes but becomes desensitized to acetylcholine [4]. This is known as a Phase II block, which clinically resembles a non-depolarizing block [4]. * **Metabolism:** Suxamethonium is metabolized by **Pseudocholinesterase** (Butyrylcholinesterase). Patients with an inherited deficiency of this enzyme experience **Succinylcholine Apnea**. * **Side Effects:** Important adverse effects include hyperkalemia (avoid in burn/trauma patients), muscle soreness, and it is a known trigger for **Malignant Hyperthermia** (Treated with Dantrolene). * **Atracurium:** Notable for undergoing **Hofmann Elimination** (spontaneous non-enzymatic degradation), making it safe in renal and hepatic failure.

Q: An example of covalent drug-receptor interaction is:

Phenoxybenzamine binding to alpha adrenergic receptor. **Explanation:** The correct answer is **D. Phenoxybenzamine binding to alpha adrenergic receptor.** **1. Why it is correct:** Most drug-receptor interactions are reversible and involve weak bonds (ionic, hydrogen, or Van der Waals). However, **Phenoxybenzamine** is a classic example of an **irreversible, non-competitive antagonist**. It undergoes a chemical transformation to form a highly reactive ethyleniminium intermediate, which then forms a **strong covalent bond** with the alpha-adrenergic receptor. Because covalent bonds are stable and difficult to break, the blockade is long-lasting (24–48 hours) and cannot be overcome by increasing the concentration of the agonist. **2. Why the other options are incorrect:** * **A & B (Noradrenaline and Acetylcholine):** These are endogenous neurotransmitters. Physiological signaling requires rapid onset and termination; therefore, they bind via **reversible, non-covalent bonds** to allow for quick dissociation and signal termination. * **C (Prazosin):** Unlike phenoxybenzamine, Prazosin is a **selective, competitive alpha-1 blocker**. It binds reversibly to the receptor, meaning its inhibitory effect can be overcome by increasing the concentration of an agonist (like Noradrenaline). **3. High-Yield Clinical Pearls for NEET-PG:** * **Clinical Use:** Phenoxybenzamine is primarily used in the preoperative management of **Pheochromocytoma** to prevent hypertensive crises. * **The "Epinephrine Reversal" (Dale’s Vasomotor Reversal):** If Epinephrine is given after Phenoxybenzamine, the alpha-mediated vasoconstriction is blocked, leaving the beta-2 mediated vasodilation unopposed, resulting in a **fall** in blood pressure. * **Other Covalent Inhibitors:** Other high-yield examples of covalent/irreversible binding include **Aspirin** (COX enzymes), **Omeprazole** (H+/K+ ATPase), and **Organophosphates** (Acetylcholinesterase).

Q: All of the following are adverse effects of atropine, except:

Bronchoconstriction. **Explanation:** Atropine is a classic **competitive muscarinic antagonist**. To understand its adverse effects, one must remember that it blocks the "Rest and Digest" (parasympathetic) system, leading to "Sympathetic-like" effects. **Why Bronchoconstriction is the Correct Answer:** In the lungs, parasympathetic stimulation via **M3 receptors** causes bronchoconstriction and increased secretions. By blocking these receptors, Atropine actually causes **bronchodilation** and decreased secretions. Therefore, bronchoconstriction is not an adverse effect; rather, its opposite (bronchodilation) is a therapeutic effect used in conditions like COPD or during anesthesia. **Analysis of Incorrect Options:** * **Tachycardia:** Atropine blocks **M2 receptors** at the SA node, removing the vagal "brake" on the heart, which leads to an increased heart rate. * **Dry Mouth (Xerostomia):** Salivary glands are highly sensitive to muscarinic blockade. Atropine inhibits **M3-mediated** salivary secretion, making dry mouth one of the most common side effects. * **Mydriasis:** By blocking **M3 receptors** on the pupillary sphincter muscle, Atropine causes passive dilation of the pupil (mydriasis) and paralysis of accommodation (cycloplegia). **NEET-PG High-Yield Pearls:** * **Mnemonic for Atropine Toxicity:** "Hot as a hare (fever), Red as a beet (flushing), Dry as a bone (no sweat/saliva), Blind as a bat (cycloplegia), Mad as a hatter (delirium)." * **Drug of Choice:** Atropine is the DOC for **symptomatic bradycardia** and **organophosphate poisoning**. * **Contraindication:** It is strictly contraindicated in patients with **narrow-angle glaucoma** (due to mydriasis) and **Benign Prostatic Hyperplasia (BPH)** (due to urinary retention).

Question 1

Which of the following is a spasmolytic analgesic?

Accepted Answer

Dicyclomine

Answer

Physostigmine

Answer

Tropicamide

Answer

None of the above

Question 2

Which of the following effects of adrenaline is reversed by prazosin but not by propranolol?

Accepted Answer

Urinary symptoms of benign prostatic hyperplasia (BHP)

Answer

Tachycardia

Answer

Bronchial dilatation

Answer

Migraine

Question 3

Which drug can improve urinary flow rate in benign prostatic hypertrophy without affecting prostate size?

Accepted Answer

Prazosin

Answer

Finasteride

Answer

Goserelin

Answer

Amphetamine

Question 4

Which of the following statements about Esmolol is true?

Accepted Answer

It is used in left ventricular decompensation.

Answer

It is an alpha blocker.

Answer

It has a long half-life.

Answer

It is not cardioselective.

Question 5

All of the following actions of histamine are mediated through H1 receptors EXCEPT?

Accepted Answer

Direct action on vascular smooth muscle causing vasodilation

Answer

Release of EDRF from vascular endothelium resulting in vasodilation

Answer

Bronchoconstriction

Answer

Release of catecholamines from adrenal medulla

Question 6

Which of the following statements is not true regarding Dobutamine?

Accepted Answer

Agonist of D1 and D2 receptors

Answer

Derivative of dopamine

Answer

Selective beta-agonistic action

Answer

Reduced chances of arrhythmia than adrenaline

Question 7

Action of which of the following drugs is rapidly terminated?

Accepted Answer

Succinylcholine

Answer

Atracurium

Answer

Pancuronium

Answer

D-tubocurarine

Question 8

Which of the following is a phase I blocker?

Accepted Answer

Suxamethonium

Answer

Atracurium

Answer

Gallamine

Answer

D-Tubocurare

Question 9

An example of covalent drug-receptor interaction is:

Accepted Answer

Phenoxybenzamine binding to alpha adrenergic receptor

Answer

Noradrenaline binding to Beta 1 adrenergic receptor

Answer

Acetylcholine binding to muscarinic receptor

Answer

Prazosin binding to alpha 1 adrenergic receptor

Question 10

All of the following are adverse effects of atropine, except:

Accepted Answer

Bronchoconstriction

Answer

Tachycardia

Answer

Dry mouth

Answer

Mydriasis

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?